On 22 November 2019, an analysis of global dementia research investment was published in The Lancet journal, by James Pickett, Head of Research at Alzheimer’s Society (UK) and Carol Brayne, Professor of Public Health Medicine at the University of Cambridge. Their article “The scale and profile of global dementia research funding” shows that the level of funding varies considerably between countries and that, while a good start has been made in the area of funding, it is imperative that it continue to rise. There is particular emphasis on the lack of investment in non-biomedical research, such as innovation for health and social care. Funding in this area falls far short of the real need, the article concludes. Read the analysis in The Lancet, here: https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(19)3259…
The Alzheimer’s Society have also written an accompanying blog post, “Dementia research investment needs to reflect the enormous cost of dementia care”, calling for the UK Government to match the level of dementia research funding to parity with other diseases and their burden. This would mean tripling current investment. They also call for GBP 100 million (EUR 117 million) of research funding to be earmarked specifically for health and social care research. Read the blog post, here: https://www.alzheimers.org.uk/for-researchers/election-manifesto-dement…
